USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Irritable Bowel Syndrome Therapeutics Markets
U.S. Irritable Bowel Syndrome Therapeutics Markets
RELEASE DATE
28-Jan-2004
28-Jan-2004
REGION
North America
North America
Research Code: A477-01-00-00-00
SKU: HC00899-NA-MR_04675
$2,450.00
In stock
SKU
HC00899-NA-MR_04675
Description
The U.S. Irritable Bowel Syndrome Therapeutics market report provides revenue forecasts, patient forecasts, competitive analysis, market trends, and product analysis. The market is segmented into anticholinergics, laxatives, antidiarrheals, antidepressants, and 5-HT modulators. Each of the segments discusses all these in detail along with product pipeline, future prospects, and competitive structure.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Scope and Segmentation
- IBS: Disorder Overview
- Introduction
- Market Engineering Analysis
Market Dynamics
- Challenges and Strategies
- Market Drivers
- Market Restraints
- Market Share Analysis
Forecasts and Trends
- Demand Analysis
- Total Market Revenue Forecast
- Market and Technology Trends
Frost & Sullivan Awards
- Patient Education Strategy Award
- Product Efficacy Award
- Technology Innovation Award
Segment Highlights
Overview
Forecasts and Competitive Analysis
Segment Highlights
Overview
Forecasts and Competitive Analysis
Segment Highlights
Overview
Forecasts and Competitive Analysis
Segment Highlights
Overview
Forecasts and Competitive Analysis
Segment Highlights
Overview
Forecasts and Trends
Competitive Analysis
Decision Support Database
Popular Topics
The U.S. Irritable Bowel Syndrome Therapeutics market report provides revenue forecasts, patient forecasts, competitive analysis, market trends, and product analysis. The market is segmented into anticholinergics, laxatives, antidiarrheals, antidepressants, and 5-HT modulators. Each of the segments discusses all these in detail along with product pipeline, future prospects, and competitive structure.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A477-01-00-00-00 |
| Is Prebook | No |